Claus Zachariae Selected Research

Claus Zachariae Research Topics

Disease

38	Hypersensitivity (Allergy) 10/2022 - 01/2003
32	Psoriasis (Pustulosis Palmaris et Plantaris) 09/2022 - 11/2003
21	Allergic Contact Dermatitis 01/2022 - 01/2006
16	Dermatitis 01/2022 - 07/2008
12	Eczema 03/2021 - 03/2003
9	Contact Dermatitis (Eczema, Contact) 01/2022 - 02/2009
4	Atopic Dermatitis (Atopic Eczema) 10/2022 - 07/2013
3	Neoplasms (Cancer) 02/2021 - 11/2012
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2021 - 01/2018
3	Infections 11/2017 - 02/2009
2	Weight Loss (Weight Reduction) 09/2022 - 12/2011
2	Rosacea (Acne Rosacea) 01/2022 - 06/2016
2	Inflammation (Inflammations) 09/2021 - 03/2013
2	Psoriatic Arthritis 05/2020 - 01/2019
2	Prurigo 04/2020 - 01/2015
2	Oral Lichen Planus 12/2017 - 06/2017
2	Stomatitis 12/2017 - 06/2017
2	Pruritus (Itching) 04/2015 - 03/2014
2	Granuloma 04/2015 - 03/2014
2	Necrosis 12/2013 - 07/2012
1	Hidradenitis Suppurativa 11/2022
1	Aphthous Stomatitis (Aphthous Ulcer) 01/2022
1	COVID-19 03/2021
1	Basal Cell Carcinoma (Rodent Ulcer) 02/2021
1	Cutaneous Lupus Erythematosus 01/2021
1	Alopecia (Baldness) 05/2020
1	Alopecia universalis 05/2020
1	Wounds and Injuries (Trauma) 01/2020
1	Nasopharyngitis 01/2020
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2019

Drug/Important Bio-Agent (IBA)

11	ChromiumIBA 11/2021 - 11/2013
10	AllergensIBA 01/2022 - 09/2012
9	NickelIBA 07/2021 - 07/2008
8	Interleukin-17 (Interleukin 17)IBA 01/2022 - 01/2014
7	CobaltIBA 07/2021 - 11/2013
7	2-methyl-4-isothiazolin-3-oneIBA 04/2021 - 09/2006
7	ixekizumabIBA 10/2019 - 03/2012
6	Pharmaceutical PreparationsIBA 01/2022 - 07/2012
6	CosmeticsIBA 04/2021 - 03/2004
6	Methotrexate (Mexate)FDA LinkGeneric 05/2020 - 01/2008
5	Glucose (Dextrose)FDA LinkGeneric 02/2021 - 09/2011
4	Biological ProductsIBA 09/2022 - 03/2018
4	Insulin (Novolin)FDA Link 02/2021 - 01/2018
4	Monoclonal AntibodiesIBA 01/2020 - 03/2012
4	Etanercept (Enbrel)FDA Link 10/2019 - 01/2008
3	hydroxyethyl methacrylate (HEMA)IBA 01/2022 - 04/2020
3	brodalumabIBA 01/2022 - 01/2014
3	VaccinesIBA 02/2021 - 03/2014
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 12/2013
3	Interleukin-23 (Interleukin 23)IBA 01/2020 - 10/2011
3	Interleukin-12 (IL 12)IBA 01/2020 - 10/2011
3	Ustekinumab (CNTO 1275)FDA Link 01/2019 - 10/2011
3	CytokinesIBA 08/2018 - 01/2014
3	Potassium Dichromate FDA Link 06/2017 - 12/2014
3	Filaggrin ProteinsIBA 11/2013 - 09/2012
2	RoflumilastIBA 11/2022 - 01/2022
2	apremilastIBA 09/2022 - 04/2020
2	PlasticsIBA 01/2022 - 01/2022
2	16S Ribosomal RNAIBA 01/2022 - 07/2021
2	chromium hexavalent ionIBA 11/2021 - 06/2017
2	Biomarkers (Surrogate Marker)IBA 10/2021 - 03/2013
2	MetalsIBA 07/2021 - 08/2020
2	Thiram FDA Link 08/2020 - 02/2016
2	dupilumabIBA 08/2020 - 07/2020
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 05/2020 - 12/2013
2	Prostaglandins AIBA 01/2020 - 12/2019
2	tildrakizumabIBA 01/2020 - 05/2015
2	Adalimumab (Humira)FDA Link 01/2019 - 01/2017
2	InterleukinsIBA 12/2017 - 05/2015
2	Proteins (Proteins, Gene)FDA Link 06/2017 - 01/2014
2	AluminumIBA 04/2015 - 03/2014
2	Glucagon-Like Peptide 1 (GLP 1)IBA 02/2013 - 12/2011
2	diazolidinylurea (diazolidinyl urea)IBA 01/2006 - 11/2005
1	Hair DyesIBA 10/2022
1	Coloring Agents (Dyes)IBA 01/2022
1	SolventsIBA 01/2022
1	mesoglycanIBA 01/2022
1	1-phenylazo-2-naphthol (Sudan I)IBA 01/2022
1	1,1',1'',1'''- (ethylenedinitrilo)tetra- 2- propanolIBA 01/2022
1	Hand SanitizersIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 10/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2021
1	Blocking AntibodiesIBA 02/2021
1	pembrolizumabIBA 01/2021
1	SesquiterpenesIBA 08/2020
1	LactonesIBA 08/2020
1	tofacitinibIBA 05/2020
1	ORALIT (ORS)IBA 03/2020
1	Immunoglobulin G (IgG)IBA 01/2020
1	AcrylatesIBA 01/2020
1	LimoneneIBA 04/2019

Therapy/Procedure

8	Therapeutics 11/2022 - 01/2008
2	Skin Care 03/2021 - 01/2018
2	Tattooing 07/2016 - 06/2013
1	Eyeglasses (Spectacles) 01/2022
1	Hand Hygiene 03/2021
1	Protective Gloves 08/2020
1	Injections 05/2020
1	Glycemic Control 01/2018
1	Artificial Pancreas 01/2018